Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8e412d4c13603158b65a529fb84b5cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fa19c20ab175e274a8aa3fedbaa980b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a65f0109d37d9916b62e663b488adbc4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P35-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10 |
filingDate |
2007-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a1d0244ab87c0a8496a20cb0ba91a8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d19f033f7124b35bde9e6e99b692f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c5e53bb247b0a860fa0755d8e557028 |
publicationDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008028654-A1 |
titleOfInvention |
Process for preparation of optically active n-protected 3 -aminopyrrolidine or optically active n-protected 3-aminopiperidine and the corresponding ketones by optical resolution of the racemic amine mixtures employing a bacterial omega-transaminase |
abstract |
The present invention relates to the production of optically active amines, which can be used as intermediate products in a synthesis of for instance pharmaceutical products. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542485-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323234-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323233-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014037376-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550370-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107604019-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107604020-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275896-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8852900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932838-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011004778-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470564-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995323-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9512410-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102471266-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9029106-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944909-B2 |
priorityDate |
2006-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |